Dogs, VR, and rock stars: OSP’s favorite items of 2021

By Jenni Spinner

- Last updated on GMT

(Image: Jenni Spinner)
(Image: Jenni Spinner)

Related tags Fda Cancer Javara Artificial intelligence cloud Aids Hiv COVID-19

It has been a pleasure for the OSP team to connect with a long list of fascinating industry minds and share the stories; here are a few of our favorites.

The pharmaceutical industry is one of the most challenging fields a trade journalist could choose to cover. However, lucky for the Outsourcing-Pharma team, it’s also one of the most fascinating, and the most rewarding. Here (in no particular order) are some of our favorite stories from 2021, which we’ve been pleased and honored to cover.

The Future of Clinical Trials series

This four-part series took a deep dive into clinical research as a care option (CRAACO), a concept that’s increasingly a topic of conversation around the industry. The articles follow in-depth conversations with two seasoned and well-respected industry professionals: Javara CEO Jennifer Byrne, and acting FDA commissioner Jennifer Woodcock.

Canine cancer research startup impacts treatment in humans

Maddow (top) and Sally O'Malley

There are several dog lovers at our company, including this humble editor (who lost her dog, Maddow, to cancer a few months ago). FidoCure is a company that seeks to develop precision cancer treatments for canines—and, in the process, potentially help come up with oncological therapies for humans. Find out more about FidoCure and hear from the CEO/co-founder.

Partnership fights to amplify Black voice in breast cancer research

Many in clinical research are very much interested in improving representation in their trials but may not know how to go about achieving that goal. This article talks about a group of committed professionals working to ensure such patients are heard and make a real difference. Learn more about their mission.

Is artificial intelligence the best tool for drug discovery?

When a new advanced technology appears on the horizon, industry professionals frequently take the ball and run with it, putting the tech to work. One leader at an artificial intelligence-focused firm cautions not to forget about the human touch. Hear his insights about the field.

Healthcare heroes make decentralized trials possible

Running DCTs is more than just sending patients home and plying them with wearables; often, the measuring and monitoring required for a study requires the help of a pro. This article talks about a company that furnishes trials around the world with experienced, trained healthcare professionals. Learn more about one of these heroes.

VR technology transforming COVID-19 drug discovery

Virtual reality is a technology most often associated with in-your-face video games. One company has taken VR from a plaything to a valuable drug discovery tech. Find out more about it here.

Cloud lab solution empowers access of research tech from miles away

Many items of lab equipment are the size of a small car and even more pricey, putting them outside the reach of many startups and other small operations. This innovative solution enables access to the high-tech gear remotely. Read about the state-of-the-art setup.

Honorable mention

(Image: Twitter, @PhizLair)

While not an article, this next item was still nonetheless memorable. December 1 is World AIDS Day, and we wanted to post something on OSP social marking the important day.

Saluting John Phair came to mind almost immediately. He’s a rock star in the field of HIV/AIDS research (read more about him in Chicago’s LGBTQ+ news site here)—and, as you might have guessed from his surname, the proud father of literal rock star Liz Phair. We posted a short tweet singing his praises, along with a pic we’d found on a few sites that depicted a charming man and his daughter, identified as John and Liz.

As it happens, it turns out the gentleman—though white-haired, bespectacled, and friendly-looking like Dr. Phair—was actually not​ the celebrated researcher. We learned this from what might be the best (and loveliest) correction ever received by a business journalist​. 

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers